Butorphanol Tartrate (Cardinal Health)


Welcome to the PulseAid listing for the Butorphanol Tartrate drug offered from Cardinal Health. This Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Cardinal Health
NON-PROPRIETARY NAME: Butorphanol Tartrate
SUBSTANCE NAME: BUTORPHANOL TARTRATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Competitive Opioid Antagonists [MoA],Opioid Agonist/Antagonist [EPC],Partial Opioid Agonists [MoA]
ROUTE: INTRAMUSCULAR; INTRAVENOUS
DOSAGE FORM: INJECTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 1998-10-15
END MARKETING DATE: 0000-00-00


Butorphanol Tartrate HUMAN PRESCRIPTION DRUG Details:

Item DescriptionButorphanol Tartrate from Cardinal Health
LABELER NAME: Cardinal Health
DEA SCHEDULE: CIV
ACTIVE STRENGTH: 2(mg/mL)
START MARKETING DATE: 1998-10-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 55154-0366_d0b63ffd-4644-4ed4-89e3-d068141e5a55
PRODUCT NDC: 55154-0366
APPLICATION NUMBER: ANDA075045

Other BUTORPHANOL TARTRATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Apotex Corp.Butorphanol Tartrate
Cardinal HealthButorphanol Tartrate
General Injectables & Vaccines, IncBUTORPHANOL TARTRATE
Hospira, Inc.Butorphanol Tartrate
Mylan Pharmaceuticals Inc.Butorphanol Tartrate
West-Ward Pharmaceuticals CorpButorphanol Tartrate
West-Ward Pharmaceuticals Corp.Butorphanol Tartrate